An ASO therapy for Angelman syndrome that targets an evolutionarily conserved region at the start of the <i>UBE3A-AS</i> transcriptScott V. Dindot, Jill L. Silverman, Paul Hillman et al.|Science Translational Medicine|2023Cited by 95
Epigenetic profiling at mouse imprinted gene clusters reveals novel epigenetic and genetic features at differentially methylated regionsScott V. Dindot, Arthur L. Beaudet, Richard Person et al.|Genome Research|2009Cited by 82
Translational outcomes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndromeElizabeth L. Berg, Jill L. Silverman, Michael C. Pride et al.|Translational Psychiatry|2020Cited by 65
Generation of a Novel Rat Model of Angelman Syndrome with a Complete <i>Ube3a</i> Gene DeletionAndie Dodge, Kevin Nash, Melinda Peters et al.|Autism Research|2020Cited by 38
Early Developmental EEG and Seizure Phenotypes in a Full Gene Deletion of Ubiquitin Protein Ligase E3A Rat Model of Angelman SyndromeHeather A. Born, Anne E. Anderson, Luis A. Martinez et al.|eNeuro|2021Cited by 30